Gregory Feldman, MD
Founding Member, Consulting MD
Pulmonary Diseases, Critical Care and Internal Medicine.
Dr. Feldman is the co-founder of MBR and one of the most experienced investigators in the world. His work on hundreds of landmark COPD and Asthma trials was essential in approving today’s leading standards of care.
During the pandemic, Dr. Feldman was the highest enrolling investigator on Moderna’s COVID-19 Vaccine study which resulted in a significant reduction in the EUA timeline of this lifesaving vaccine.
Dr. Feldman’s extensive experience informs MBR’s Standard Operating Procedures, optimizing high patient enrollment without compromising rigorous compliance with Good Clinical Practice.
After attending medical school at Second Moscow Medical Institute, Dr. Feldman completed his Pulmonary and Critical Care training at Dartmouth-Hitchcock Medical Center, Hanover, NH.